Robuta

https://www.mdpi.com/2072-6694/14/14/3353
Simple SummaryTrastuzumab administered as a (neo)adjuvant therapy in radically treated Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer...
cardiac toxicitybiomarkerstrastuzumabinducedpositive